ELAB vs. ABVC, MBRX, MIRA, MTEM, AKTX, IMNN, GHSI, ADXN, AEZS, and PPBT
Should you be buying Elevai Labs stock or one of its competitors? The main competitors of Elevai Labs include ABVC BioPharma (ABVC), Moleculin Biotech (MBRX), MIRA Pharmaceuticals (MIRA), Molecular Templates (MTEM), Akari Therapeutics (AKTX), Imunon (IMNN), Guardion Health Sciences (GHSI), Addex Therapeutics (ADXN), Aeterna Zentaris (AEZS), and Purple Biotech (PPBT). These companies are all part of the "pharmaceutical preparations" industry.
ABVC BioPharma (NASDAQ:ABVC) and Elevai Labs (NASDAQ:ELAB) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, community ranking, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.
ABVC BioPharma and Elevai Labs both received 0 outperform votes by MarketBeat users.
Elevai Labs has a net margin of 0.00% compared to Elevai Labs' net margin of -6,919.08%. ABVC BioPharma's return on equity of 0.00% beat Elevai Labs' return on equity.
In the previous week, ABVC BioPharma and ABVC BioPharma both had 4 articles in the media. ABVC BioPharma's average media sentiment score of 0.44 beat Elevai Labs' score of 0.40 indicating that Elevai Labs is being referred to more favorably in the news media.
11.4% of ABVC BioPharma shares are held by institutional investors. Comparatively, 22.2% of Elevai Labs shares are held by institutional investors. 11.9% of ABVC BioPharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Elevai Labs has higher revenue and earnings than ABVC BioPharma.
Summary
Elevai Labs beats ABVC BioPharma on 7 of the 9 factors compared between the two stocks.
Get Elevai Labs News Delivered to You Automatically
Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ELAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Elevai Labs Competitors List
Related Companies and Tools
